Ole Olsen
33Patents
5h-index
34Co-inventors
65Inventor score
Filing activity: Nov 12, 2008 → Jun 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9051362B2 | Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity | Chemistry; Metallurgy | 14 | Active |
| US9464131B2 | Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody | Chemistry; Metallurgy | 14 | Active |
| US10087239B2 | Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody | Chemistry; Metallurgy | 12 | Active |
| US8916160B2 | Compositions and methods for the therapy and diagnosis of influenza | Physics | 8 | Active |
| US8057796B2 | Compositions and methods for the therapy and diagnosis of influenza | Chemistry; Metallurgy | 6 | Active |
| US10570191B2 | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US8114402B2 | Compositions and methods for the therapy and diagnosis of influenza | Chemistry; Metallurgy | 4 | Active |
| US11192941B2 | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8460671B2 | Compositions and methods for the therapy and diagnosis of influenza | Chemistry; Metallurgy | 2 | Active |
| US11319362B2 | Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies | Chemistry; Metallurgy | 2 | Active |
| US8268309B2 | Compositions and methods for the therapy and diagnosis of cytomegalovirus | Physics | 2 | Active |
| US8900590B2 | Anti-hemagglutinin antibody compositions and methods of use thereof | Physics | 2 | Active |
| US11787863B2 | Multi-specific antibodies and methods of making and using thereof | Chemistry; Metallurgy | 1 | Active |
| US12029761B2 | Guidance and Navigation Control proteins and method of making and using thereof | Chemistry; Metallurgy | 1 | Active |
| US11518815B2 | Anti-ROR1 antibodies and methods of making and using thereof | Chemistry; Metallurgy | 1 | Active |
| US7982012B2 | Compositions and methods for the therapy and diagnosis of cytomegalovirus | Physics | 1 | Active |
| US8852594B2 | Compositions and methods for the therapy and diagnosis of cytomegalovirus infections | Physics | 1 | Active |
| US8974788B2 | Compositions and methods for the therapy and diagnosis of influenza | Physics | 1 | Active |
| US8858948B2 | Compositions and methods for the therapy and diagnosis of influenza | Chemistry; Metallurgy | 1 | Active |
| US11987635B2 | Anti-4-1BB antibodies and methods of making and using thereof | Chemistry; Metallurgy | 0 | Active |
| US11584789B2 | Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity | Chemistry; Metallurgy | 0 | Active |
| US10407493B2 | Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity | Chemistry; Metallurgy | 0 | Active |
| US10239934B2 | Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity | Chemistry; Metallurgy | 0 | Active |
| US11535667B2 | Anti-CD3 antibodies and methods of making and using thereof | Chemistry; Metallurgy | 0 | Active |
| US11649286B2 | Tri-specific antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.